Lengthy EU Regulatory Review Ends Well For Roche’s NMOSD Therapy

 
• By Neena Brizmohun

The European Medicines Agency has finally recommended pan-EU marketing approval for Roche’s Enspryng.

NMOSD is a debilitating autoimmune disorder of the central nervous system • Source: Alamy

More from Europe

More from Geography